Literature DB >> 9698032

Placental membrane fatty acid-binding protein preferentially binds arachidonic and docosahexaenoic acids.

F M Campbell1, M J Gordon, A K Dutta-Roy.   

Abstract

To elucidate further the role of placental membrane fatty acid-binding protein (p-FABPpm) in preferential transfer of maternal plasma long chain polyunsaturated fatty acids (LCPUFA) across the human placenta, direct binding of the purified protein with various radiolabelled fatty acids (docosahexaenoic, arachidonic, linoleic and oleic acids) was investigated. Binding of these fatty acids to the protein revealed that p-FABPpm had higher affinities and binding capacities for arachidonic and docosahexaenoic acids compared with linoleic and oleic acids. The apparent binding capacities (Bmax) values for oleic, linoleic, arachidonic and docosahexaenoic acids were 2.0 +/- 0.14, 2.1 +/- 0.17, 3.5 +/- 0.11, 4.0 +/- 0.10 mol per mol of p-FABPpm whereas the apparent dissociation constant (Kd) values were 1.0 +/- .0.07, 0.73 +/- 0.04, 0.45 +/- 0.03 and 0.4 +/- 0.02 microM, respectively (n=3). In the case of human serum albumin, the Kd and Bmax values for all fatty acids were around 1 microM and 5 mol/mol of protein, respectively. These data provide direct evidence for the role of p-FABPpm in preferential sequestration of maternal arachidonic and docosahexaenoic acids by the placenta for transport to the fetus by virtue of its preferential binding of these fatty acids.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9698032     DOI: 10.1016/s0024-3205(98)00267-7

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  15 in total

Review 1.  Docosahexaenoic Acid: Outlining the Therapeutic Nutrient Potential to Combat the Prenatal Alcohol-Induced Insults on Brain Development.

Authors:  Bradley A Feltham; Xavier L Louis; Michael N A Eskin; Miyoung Suh
Journal:  Adv Nutr       Date:  2020-05-01       Impact factor: 8.701

2.  Transport of Docosahexaenoic Acid via the Human Placenta: A Theoretical Study.

Authors:  Efrath Barta
Journal:  J Membr Biol       Date:  2019-09-25       Impact factor: 1.843

Review 3.  Maternal fatty acid status during pregnancy and lactation and relation to newborn and infant status.

Authors:  Lotte Lauritzen; Susan E Carlson
Journal:  Matern Child Nutr       Date:  2011-04       Impact factor: 3.092

Review 4.  Fatty acid transporting proteins: Roles in brain development, aging, and stroke.

Authors:  Wenting Zhang; Ruiying Chen; Tuo Yang; Na Xu; Jun Chen; Yanqin Gao; R Anne Stetler
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2017-04-21       Impact factor: 4.006

Review 5.  Maternal PUFAs, Placental Epigenetics, and Their Relevance to Fetal Growth and Brain Development.

Authors:  Sanjay Basak; Asim K Duttaroy
Journal:  Reprod Sci       Date:  2022-06-08       Impact factor: 3.060

6.  Analysis of FA contents in individual lipid fractions from human placental tissue.

Authors:  M Klingler; H Demmelmair; E Larque; B Koletzko
Journal:  Lipids       Date:  2003-05       Impact factor: 1.880

Review 7.  Transmembrane movement of exogenous long-chain fatty acids: proteins, enzymes, and vectorial esterification.

Authors:  Paul N Black; Concetta C DiRusso
Journal:  Microbiol Mol Biol Rev       Date:  2003-09       Impact factor: 11.056

8.  Role of liver and plasma lipoproteins in selective transport of n-3 fatty acids to tissues: a comparative study of 14C-DHA and 3H-oleic acid tracers.

Authors:  Alla Polozova; Norman Salem
Journal:  J Mol Neurosci       Date:  2007-09       Impact factor: 3.444

Review 9.  Long chain fatty acids and dietary fats in fetal nutrition.

Authors:  Irene Cetin; Gioia Alvino; Manuela Cardellicchio
Journal:  J Physiol       Date:  2009-06-15       Impact factor: 5.182

10.  Reduced neonatal mortality in Meishan piglets: a role for hepatic fatty acids?

Authors:  Hernan P Fainberg; Katherine Bodley; Jaume Bacardit; Dongfang Li; Frank Wessely; Nigel P Mongan; Michael E Symonds; Lynne Clarke; Alison Mostyn
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.